Enlivex Therapeutics Ltd. (ENLV)
NASDAQ·Healthcare·Biotechnology
$0.60
-6.71%
Mkt Cap $28.19M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+2395.8%
Consensus $15.00 vs current $0.60
NASDAQ·Healthcare·Biotechnology
$0.60
-6.71%
Mkt Cap $28.19M
Buy
2
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+2395.8%
Consensus $15.00 vs current $0.60